101 related articles for article (PubMed ID: 10772726)
1. Preclinical antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)adenine (Cl-F-ara-A).
Waud WR; Schmid SM; Montgomery JA; Secrist JA
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):447-60. PubMed ID: 10772726
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
King KM; Damaraju VL; Vickers MF; Yao SY; Lang T; Tackaberry TE; Mowles DA; Ng AM; Young JD; Cass CE
Mol Pharmacol; 2006 Jan; 69(1):346-53. PubMed ID: 16234483
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells.
Parker WB; Shaddix SC; Rose LM; Shewach DS; Hertel LW; Secrist JA; Montgomery JA; Bennett LL
Mol Pharmacol; 1999 Mar; 55(3):515-20. PubMed ID: 10051535
[TBL] [Abstract][Full Text] [Related]
4. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine.
Xie KC; Plunkett W
Cancer Res; 1996 Jul; 56(13):3030-7. PubMed ID: 8674058
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells.
Xie C; Plunkett W
Cancer Res; 1995 Jul; 55(13):2847-52. PubMed ID: 7540950
[TBL] [Abstract][Full Text] [Related]
6. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
Parker WB; Shaddix SC; Chang CH; White EL; Rose LM; Brockman RW; Shortnacy AT; Montgomery JA; Secrist JA; Bennett LL
Cancer Res; 1991 May; 51(9):2386-94. PubMed ID: 1707752
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration.
Takahashi T; Kanazawa J; Akinaga S; Tamaoki T; Okabe M
Cancer Chemother Pharmacol; 1999; 43(3):233-40. PubMed ID: 9923554
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 4'-thio-beta-D-arabinofuranosylcytosine (4'-thio-ara-C) and comparison of its anticancer activity with that of ara-C.
Tiwari KN; Shortnacy-Fowler AT; Cappellacci L; Parker WB; Waud WR; Montgomery JA; Secrist JA
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):329-40. PubMed ID: 10772718
[TBL] [Abstract][Full Text] [Related]
9. Preclinical antitumor activity of 4'-thio-beta-D-arabinofuranosylcytosine (4'-thio-ara-C).
Waud WR; Gilbert KS; Shepherd RV; Montgomery JA; Secrist JA
Cancer Chemother Pharmacol; 2003 May; 51(5):422-6. PubMed ID: 12679884
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
Bagley RG; Roth S; Kurtzberg LS; Rouleau C; Yao M; Crawford J; Krumbholz R; Lovett D; Schmid S; Teicher BA
Int J Oncol; 2009 May; 34(5):1329-40. PubMed ID: 19360345
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
Parker WB; Shaddix SC; Gilbert KS; Shepherd RV; Waud WR
Cancer Chemother Pharmacol; 2009 Jul; 64(2):253-61. PubMed ID: 19002461
[TBL] [Abstract][Full Text] [Related]
12. In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
Kano Y; Akutsu M; Tsunoda S; Suzuki K; Ichikawa A; Furukawa Y; Bai L; Kon K
Leukemia; 2000 Mar; 14(3):379-88. PubMed ID: 10720130
[TBL] [Abstract][Full Text] [Related]
13. Effect of fludarabine and arabinosylcytosine on multidrug resistant cells.
Michelutti A; Michieli M; Damiani D; Melli C; Ermacora A; Grimaz S; Candoni A; Russo D; Fanin R; Baccarani M
Haematologica; 1997; 82(2):143-7. PubMed ID: 9175315
[TBL] [Abstract][Full Text] [Related]
14. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.
Yamauchi T; Nowak BJ; Keating MJ; Plunkett W
Clin Cancer Res; 2001 Nov; 7(11):3580-9. PubMed ID: 11705880
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of the apoptotic activity of Cl-F-araA in a human T-ALL cell line, CCRF-CEM.
Takahashi T; Shimizu M; Akinaga S
Cancer Chemother Pharmacol; 2002 Sep; 50(3):193-201. PubMed ID: 12203101
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of 4'-C-hydroxymethyl-2'-fluoro-D-arabinofuranosylpurine nucleosides.
Shortnacy-Fowler AT; Tiwari KN; Montgomery JA; Secrist JA
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):747-50. PubMed ID: 11563107
[TBL] [Abstract][Full Text] [Related]
18. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-beta-D-arabinofuranosyl-2-fluoroadenine.
Bai L; Yamaguchi M; Tatsumi M; Kon K; Bräutigam M
J Cancer Res Clin Oncol; 1998; 124(7):367-73. PubMed ID: 9719499
[TBL] [Abstract][Full Text] [Related]
20. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Hapke DM; Stegmann AP; Mitchell BS
Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
